Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213622) titled 'The Use of Smart Glasses for Saphenous Nerve Adductor Canal Block' on Oct. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: MetroHealth Medical Center

Condition: Total Knee Arthroplasty

Intervention: Procedure: Smartglasses

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: March 4, 2024

Target Sample Size: 100

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07213622

Published by HT Digital Content Service...